Evolus, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $297.2M | $266.3M | $202.1M | $148.6M | $99.7M |
| Gross profit | $197.1M | $182.3M | $137.6M | $89.8M | — |
| Operating income | -$32.7M | -$34.4M | -$49.2M | -$65.3M | -$44.4M |
| Cost of revenue | $100.1M | $84.0M | $64.5M | $58.8M | $43.5M |
| Cash from operations | -$42.3M | -$18.0M | -$34.0M | -$84.9M | -$33.4M |
| Capital expenditure | $3.4M | $1.5M | $473,000 | $1.6M | $393,000 |
| Free cash flow | -$45.7M | -$19.5M | -$34.5M | -$86.5M | -$33.8M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $225.9M | $232.6M | $189.0M | $178.0M | $257.5M |
| Total liabilities | $249.0M | $227.0M | $209.7M | $159.5M | $175.6M |
| Total debt | $150.0M | $125.0M | $125.0M | $75.0M | $75.0M |
Shares outstanding 65.9M · Free float 81.2%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.